-
Subject Areas on Research
-
A comparative transcriptomic analysis of astrocytes differentiation from human neural progenitor cells.
-
Accelerated cell cycles enable organ regeneration under developmental time constraints in the Drosophila hindgut.
-
Akt is required for Stat5 activation and mammary differentiation.
-
Beta-arrestins and cell signaling.
-
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.
-
Constitutive Interferon Maintains GBP Expression Required for Release of Bacterial Components Upstream of Pyroptosis and Anti-DNA Responses.
-
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I.
-
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.
-
Enterovirus 2Apro Cleavage of the YTHDF m6A Readers Implicates YTHDF3 as a Mediator of Type I Interferon-Driven JAK/STAT Signaling.
-
Exercise mimetics and JAK inhibition attenuate IFN-γ-induced wasting in engineered human skeletal muscle.
-
Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.
-
High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease.
-
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.
-
Inositol phosphate kinase 2 is required for imaginal disc development in Drosophila.
-
Interorgan regulation of Drosophila intestinal stem cell proliferation by a hybrid organ boundary zone.
-
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.
-
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.
-
JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats.
-
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.
-
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
-
Mining database for the expression and gene regulation network of JAK2 in skin cutaneous melanoma.
-
Requirement for JAK/STAT signaling throughout border cell migration in Drosophila.
-
SOCS36E, a novel Drosophila SOCS protein, suppresses JAK/STAT and EGF-R signalling in the imaginal wing disc.